Design of a superior cytokine antagonist for topical ophthalmic use-Reference-Cited by-同舟云学术

Design of a superior cytokine antagonist for topical ophthalmic use

Published:2013-02-19 Issue:10 Volume:110 Page:3913-3918
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Hou J.,Townson S. A.,Kovalchin J. T.,Masci A.,Kiner O.,Shu Y.,King B. M.,Schirmer E.,Golden K.,Thomas C.,Garcia K. C.,Zarbis-Papastoitsis G.,Furfine E. S.,Barnes T. M.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference45 articles.

1. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

2. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation

3. IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage

4. Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome

5. Immunological and Inflammatory Functions of the Interleukin-1 Family

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

2. Developing a platform for secretion of biomolecules in Mycoplasma feriruminatoris;Microbial Cell Factories;2024-04-30

3. Ganoderic acid A targets IL-1R1 and disrupts IL-1β binding in human cancer cells;Journal of Molecular Structure;2024-04

4. IL-1 Receptor Dynamics in Immune Cells: Orchestrating Immune Precision and Balance;Immune Network;2024

5. A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma;Blood Advances;2023-11-14